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Antimetabolites, e. g., methotrexate (MTX), cyto-
sine arabinoside (Ara-C) and 5-fluorouracil (5-FU), 
are widely used drugs in anti-tumor therapy. However, 
the currently used antimetabolites have not displayed 
sa tisfactory results in the clinical treatment of solid 
tumors and leukemia. Originally antimetabolites were 
thought to inhibit the activities of enzymes for de novo 
pathways in nucleic acid biosynthesis. However, in 
cancer cells the activities of enzymes for salvage 
pathway of nucleic acid biosynthesis are also high. 
So, researchers proposed to combine inhibitors of key 
enzymes for de novo pathways of nucleic acid biosyn-
thesis with blockers of the salvage pathway [1, 2].
Recently, we have observed the phenomenon that 
the anti-tumor activity of azaserine, one of the antime-
tabolites used for in vitro studies of human erythrogenic 
leukemia cell line K-562, was altered by different culture 
medium. The anti-tumor activity was higher in a serum-
free medium Cosmedium-001 than in another serum-
free medium –ASF 104, or modified minimum essential 
medium (MEM) with 10% fetal calf serum (FCS).
MATERIALS AND METHODS
Cells, medium and FCS. A human erythroid 
leukemia cell line K-562 was maintained in 10% FCS 
modified Eagle’s minimum essential medium (MEM). 
Modified MEM was composed of 2 mM L-glutamine, 
5 x 10–5 M 2-mercaptoethanol, 25 mM HEPES and 
MEM. Two serum-free media, Cosmedium-001 and 
ASF 104 were purchased from Cosmo Bio Co., Ltd. 
(Tokyo, Japan) and AJINOMOTO Co., Ltd. (Tokyo, 
Japan), respectively. Two lots (SFB30-1674 & 1663) of 
FCS were purchased from Equitec-Bio, Inc. (TX, USA), 
and inactivated by incubation at 56 °C for 30 min. Bo-
vine serum albumin (BSA) was purchased from Sigma 
Chemical Co. Ltd. (St. Louis, MO, USA).
Antimetabolites. Azaserine, 5-FU, MTX, Ara-C and 
trimethoprim were purchased from Sigma Chemical 
Co. Ltd. (St. Louis, MO, USA). Drugs were used at follow-
ing concentrations: 10–40 μM, 500–2000 ng/ml, 0.025–
0.1 μM, 25–100 μg/ml and 0.25–1 mM, respectively.
Human serum albumin. Albumin (25%) Cutter 
(D419) and albumin from human serum (ALF0020) 
were purchased from Bayer in Japan (Osaka, Japan) 
and Wako Pure Chemical Industries Ltd. (Osaka, Ja-
pan), respectively.
Ultrafiltration. FCS or medium was filtered with 
the use of Amicon centrifugal filter devices, YM-30 
(nominal molecular weight: > 30 kDa) and YM-100 
(nominal molecular weight: > 100 kDa) (Millipore Cor-
poration, Bedford, MA, USA). Preliminary experiments 
showed that retentates of ultrafiltration with YM-30 
and -100 contained molecules with molecular weight 
30 kDa and 100 kDa, respectively. Both filtrate and re-
tentate were reconstituted with the starting medium.
Estimation of anti-tumor activity. Human leuke-
mic cells, mainly K-562 cells (5 x 103/well) were incu-
bated with several factors in 96-well round-bottomed 
microtiter plates, each well containing 200 μl of medium 
at 37 °C for 48 h. Then, the number of viable cells was 
estimated by measuring the activity of released LDH 
from viable cells using a kit, CytoTox 96® Non-Radioac-
tive Cytotoxicity Assay (Promega Corporation, USA).
Two-dimensional electrophoresis and mass 
spectrometric analysis of proteins. In order to de-
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tect factors, responsible for the effect of FCS, we have 
used the technical services of Towa Kankyo Kagaku 
Co. Ltd. (Hiroshima, Japan). Two lots of FCS (active 
and no activat) were separated by 2-dimenshonal 
electrophoresis, and analyzed by mass spectrometry. 
Isoelectric focusing (IEF) was performed using Im-
mobiline dry strip pH 4–7 (GE Healthcare UK Ltd.) and 
Ampholine pH 3.5–10. Solubilized protein (100 μg) was 
loaded onto a strip. SDS-PAGE was performed using 
9–18% gradient gels. Protein spots were detected by 
SYPRO Ruby staining (Invitrogen, CA, USA).
Protein spots were excised from the 2-D gels, 
washed twice with Milli-Q water, and dehydrated in 
100% acetonitrile (ACN) until they turned opaque white. 
The spots were then dried in a vacuum centrifuge, and 
subsequently rehydrated in 10 μl of digestion solution 
consisting of 50 mM NH4HCO3, 5 mM CaCl2, 0.01 μg/μl 
modified sequence-grade trypsin (Promega). After 16 h 
incubation at 37 °C the digestion was terminated by 
ad ding 10 μl of 5% trifluoroacetic acid (TFA). Peptides 
were extracted 3 times for 20 min with 50 μl of 5% TFA, 
50% ACN, and the extracts were pooled and dried in 
a vacuum centrifuge. The dried materials were resus-
pended in 10 μl of 0.1% TFA. To remove excess salts 
from the extracts, solid-phase extraction was performed 
using C18 ZipTip (Millipore) according to the manufac-
turer’s instruction. Peptides were eluted from ZipTip by 
3 μl of 50% ACN, 0.1% TFA and 1 μl of the eluants were 
spotted onto a target plate. Then, the spots on the target 
plate were immediately mixed with 0.5 μl of a matrix so-
lution containing 0.3 mg/ml α-cyano-hydroxycinnamic 
acid, 33% acetone, 66% ethanol, and were completely 
air-dried at room temperature. MS and MS/MS spectra 
were obtained using an Ultraflex TOF/TOF mass spec-
trometer (Bruker Daltonics). An external peptide mixture 
was used to calibrate the instrument. Identification of 
proteins was carried out using the MASCOT software 
(Matrix Science) and de novo sequencing.
Albumin depletion. Depletion of albumin from 
FCS was performed with Vivapure® Anti-HSA Kit for 
human albumin depletion (Sartorius Biotech GmbH, 
Goettingen, Germany), which is based on an antibody 
to human serum albumin (HSA) or MontageTM Albumin 
Deplete Kit (Millipore Corporation, Bedford, MA, USA), 
which is based on an affinity resin, respectively. In case 
of MontageTM Albumin Deplete Kit, albumin depletion 
(more than 50%) was confirmed using SDS-PAGE. 
Both methods require buffer to deplete albumin from 
FCS. So the buffer was removed using a centrifugal 
concentrator, Apollo® 7 ml (Orbital Biosciences, LLC, 
Topsfield, MA, USA), and the obtained albumin-
depleted FCS was reconstituted with PBS.
Statistics. Difference between 2 groups was 
evaluated using two-tailed Student’s t-test or Welch’s 
test. P values of 5 or less% were considered statisti-
cally significant.
RESULTS
Cytotoxic effect of antimetabolites on 
K-562 cells. Fig. 1, a, b shows that K-562 cells were 
more sensitive to azaserine and MTX when cultured 
in Cosmedium-001 than in ASF 104 or 10% FCS 
modified MEM. Anti-tumor activity of other analyzed 
antimetabolites (5-FU, Ara-C and trimethoprim) was 
not affected by culture media (Fig. 1, c–e).
Effect of FCS on anti-tumor activities of anti-
metabolites against K-562 cells cultured in Cos-
medium-001. In order to examine why anti-tumor 
activities of MTX and azaserine were attenuated when 
K-562 cells were cultured in 10% FCS modified MEM, 
cells were cultured in Cosmedium-001 with 10% FCS. 
It was shown that anti-tumor activity of 5-FU was not 
altered by this medium. However, the anti-tumor activi-
ties of MTX and azaserine were attenuated.
Suppressive effect of different FCS lots on the 
anti-tumor activity of MTX. Fig. 3 shows that 10% FCS 
of lot No.1674, but not lot No.1663 attenuated the anti-
tumor activity of MTX. Lot No.1674 showed the highest 
activity among other tested lots of FCS, and the effect 
of lot No.1664 was minimal (data not shown).
Molecular weights of the FCS molecules that 
suppress the anti-tumor activity of MTX. Ultra-
filtration showed that FCS molecules 100 kDa from 
lot No.1674 attenuated the cytotoxic effect of MTX 
(Fig. 4). However, a preliminary experiments revealed 
that this fraction actually contained molecules with ap-
proximate weight of 64.2 kDa (data not shown).
Two-dimensional electrophoresis of both lots 
of FCS. Fig. 5, a, b shows that the FCS (lot No.1674) 
contained proteins with molecular weight of 150 kDa 
(a), which were absent in the FCS (lot No.1663) (b). 
Mass spectrometry showed that those proteins had 
the same amino acid sequence as albumin.
Effect of albumin depletion on the suppressive 
activity of the FCS. Fig. 6 shows that depleting albu-
min from FCS (lot No.1674) with 2 different methods 
(antibodies and affinity resin) attenuated its suppres-
sive effect on anti-tumor activity of MTX.
Effect of human sera on the anti-tumor activity 
of MTX. Fig. 7 shows that sera of one female healthy 
volunteer and two female patients with thyroid cancer 
at a concentration of 5% completely abrogated the 
cytotoxic effect of MTX against K-562 cells cultured 
in Cosmedium-001 and that the activity of individual 
serum was different at concentrations of 0.05–0.5%.
Effects of HSA on the anti-tumor activity of MTX. 
It is well-known that the concentration of human serum 
albumin (HSA) in serum is 30~40 mg/ml. Five percent of 
human serum (1.5~2 mg/ml HSA) attenuated the anti-
tumor activity of MTX (Fig. 7). So, we decided to test the 
ability of two HSA preparations at the concentration of 
5 mg/ml, produced by different manufacturers, to sup-
press the anti-tumor activity of MTX (Fig. 8, a). One of the 
HSA preparations (Wako), lost its activity at a concentration 
of 10 mg/ml. A bovine serum albumin did not exert such 
an activity (data not shown). SDS-PAGE shows that not the 
BSA solution but the HSA (Wako) contained proteins with 
molecular weight of approximately 200 kDa (Fig. 8, b).
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Fig. 1. Cytotoxic effect of antimetabolites on K-562 cells cul-
tured in 3 different media. K-562 cells were incubated with the 
indicated concentration of antimetabolite, azaserine (a), MTX (b), 
5-FU (c), Ara-C (d) and trimethoprim (e) in Cosmedium-001 ( ), 
ASF 104 ( ) or 10% FCS modified MEM ( ) at 37 °C for 48 h. Verti-
cal bars represent standard deviation (SD) of 4 determinants
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Fig. 2. Effect of FCS on anti-tumor activities of antimetabolites 
against K-562 cells cultured in Cosmedium-001. K-562 cells 
were incubated with ( ) or without ( ) 0.1 μM MTX, 40 μM aza-
serine or 2000 ng/ml 5-FU in Cosmedium-001 containing 10% 
FCS < FCS (+) > or without FCS < FCS (−) > at 37 °C for 48 h. 
Vertical bars represent SD of 4 determinants
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Fig. 3. Difference between two lots of FCS in their suppressive 
effect on the anti-tumor activity of MTX. K-562 cells were incu-
bated without ( ), or with 0.05 μM ( ) or 0.1 μM ( ) of MTX in 
Cosmedium-001 in the presence of 10% FCS (lot No.1663 & 1674) 
or with no FSC at 37 °C for 48 h. Vertical bars represent SD of 
4 determinants. aNot significant (NS), bp < 0.05, c, dp < 0.001.
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Fig. 4. The molecular weights of the molecules in the FCS that 
suppressed the anti-tumor activity of MTX. K-562 cells were 
incubated with ( ) or without ( ) 0.1μM MTX in 180 μl of Cos-
medium-001 and 20 μl of the indicated FCS fraction at 37 °C for 
48 h. Vertical bars represent SD of 4 determinants. ap < 0.01.
Effect of pre- or simultaneous treatment of 
K-562 cells with the FCS on the cytotoxicity of 
MTX. Fig. 9 shows that pre-incubation of K-562 cells 
with 10% FCS for 48 h did not attenuate their sensi-
tivity to MTX, but only the simultaneous incubation of 
K-562 cells with 10% FCS and MTX had such effect.
Interaction between MTX and the suppres-
sive molecules in the FCS. MTX (0.2 μM) and FCS 
(lot No.1674) (20%) were incubated at 37 °C for 24 h. 
Their concentrations were 2 times higher than those in 
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the other experiments since they were finally diluted 
to 0.1 μM (MTX) and 10% (FCS). Upon filtration by 
YM-100 filter, the anti-tumor activities of both filtrates 
and retentates were examined. Fig. 10 shows that the 
filtrate of MTX without the FCS exerted its anti-tumor 
activity. On the other hand, the filtrate of MTX incubated 
with the FCS did not exert its anti-tumor activity. Each 
retentate of MTX incubated with or without the FCS 
exerted weak anti-tumor activity to the same degree.
DISCUSSION
Many authors reported that albumin functions as 
a carrier for a variety of molecules. Albumin is the 
principle carrier of fatty acids [3–5], bilirubin [4, 5], 
metals including zinc [5, 6], hormones [7] and several 
important classes of drugs, e. g., calcium blockers, 
diuretics and non-steroidal anti-inflammatory drugs 
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Fig. 5. Two-dimensional electrophoresis of two lots of FCS. The 
active FCS (No. 1674) (a) and the not active FCS (No. 1663) (b). 
Spots indicated by circles were specific in each FCS
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Fig. 6. Effect of albumin depletion on the suppressive activity 
of the FCS. K-562 cells were incubated with indicated fractions 
(10%) in the presence ( ) or absence ( ) of 0.1 μM MTX in 
Cosmedium-001 at 37 °C for 48 h. Albumin depletion: Vivapure 
®Anti-HSA Kit (a), Montage Albumin Depletion Kit (b). Vertical 
bars represent SD of 4 determinants. ap < 0.01, bp < 0.001, 
cp < 0.05 (one-tailed),dp < 0.05.
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Fig. 7. Effect of human sera on the anti-tumor activity of MTX. 
K-562 cells were incubated with ( ) or without ( ) 0.1 μM MTX 
in Cosmedium-001 containing the indicated concentrations 
of individual human serum at 37 °C for 48 h. TS, TT and MM 
represent initials of volunteers. Vertical bars represent SD of 
4 determinants.
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 5 10 0 5 10
Wako Bayer
HSA (mg/ml)
O
D4
92
a
a
b 
b
c
Origin —
204 kDa —
121 kDa —
82 kDa —
50.2 kDa —
34.2 kDa —
28.1 kDa —
19.3 kDa —
Std H B
— *
a
b
Fig. 8. Effect of HSA on the anti-tumor activity of MTX. K-562 cells 
were incubated with the indicated concentrations of HSA produced 
by two manufacturers, Wako and Bayer, in the presence ( ) or ab-
sence ( ) of 0.1 μM MTX in Cosmedium-001 at 37 °C for 48 h (a). 
Vertical bars represent SD of 4 determinants. ap < 0.05, bp < 0.001, 
cp < 0.05. Wako’s HSA (H) and BSA (B) were analyzed by SDS-
PAGE (b). *Shows that HSA had indicated band, but BSA did not.
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[5]. All these authors consider albumin as a carrier 
molecule, especially Kratz [4] and his colleagues [8]. 
The present study suggested that proteins with high 
molecular weight derived from albumin (possibly its 
dimers or trimers) could bind MTX, and suppress its 
anti-tumor activity.
K-562 cells cultured in Cosmedium-001 were more 
sensitive to cytotoxic effect of azaserine and MTX than 
cells cultured in ASF 104 and 10% FCS modified MEM. 
The cytotoxic effect of other antimetabolites, 5-FU, 
Ara-C and trimethoprim against K-562 cells was not 
altered by culture media. When some lots of FCS were 
added to Cosmedium-001 at a concentration of 10%, 
MTX and azaserine exerted low anti-tumor activities to 
K-562 cells as compared with Cosmedium-001 alone. 
This finding suggests that some factors in the FCS 
were responsible for suppressing the anti-tumor activi-
ties of both drugs. Lower anti-tumor activities of MTX 
and azaserine to K-562 cells cultured in ASF 104 than 
in Cosmedium-001, remain to be clarified.
The two-dimensional electrophoresis showed 
that the active FCS contained proteins with molecular 
weights 150 kDa, which were absent in the not active 
FCS lot. Mass spectrometry analysis revealed that those 
proteins had the same amino acid sequence as albumin. 
It seems that these proteins with high molecular weight 
are complexes of albumin. When albumin was depleted 
from the active FCS by means of 2 different methods 
(albumin binding affinity resin and anti-human serum al-
bumin antibody), its suppressive activity was clearly at-
tenuated. All tested human sera (one healthy volunteer 
and two patients with thyroid cancer) suppressed the 
anti-tumor activity of MTX against K-562 cells cultured 
in Cosmedium-001. Most of HSA samples are expected 
to exert such an activity. In fact, 2 tested commercially 
available HSA preparations exerted the activity. In any 
case, the activity of a larger number of human sera 
remains to be examined.
We hypothesized that the FCS did not resolve 
MTX chemically, but bound it. We suppose that pos-
sibly such MTX-binding molecules are complexes of 
albumin.
REFERENCES
Weber G. 1. Biochemical strategy of cancer cells and the 
design of chemotherapy. G.H.A. Clowes memorial lecture. 
Cancer Res 1983; 43: 3466–92.
Weber G, Projda N. 2. Targeted and non-targeted actions 
of anti-cancer drugs. Advan Enzyme Regul 1994; 34: 71–89.
Sen P, Fatima S, Khan JM, 3. et al. How methyl cyanide 
induces aggregation in all-alpha proteins: A case study in four 
aibumins. Int J Bio Macromol 2009; 44: 163–9.
Kratz F. 4. Albumin as a drug carrier: design of prodrug, 
drug conjugates and nanoparticles. J Controlled Release 2008; 
132: 171–83.
Meijers BKI, Bammens B, Verbeke K, 5. et al. A review of al-
bumin binding in CKD. Am J Kidney Dis 2008; 51: 839–50.
Lu J, Stewart AJ, Sadler PJ, 6. et al. Albumin as a zinc car-
rier: properties of its high-affinity zinc-binding site. Biochem 
Soc Trans 2008; 36: 1317–21.
Baker ME. 7. Beyond carrier proteins. Albumin, steroid 
hormones and the origin of vertebrates. J Endocrinol 2002; 
175: 121–7.
Fiehn C, Kratz F, Sass G, 8. et al. Targeted drug delivery by 
in vivo coupling to endogenous albumin: an albumin-binding 
prodrug of methotrexate (MTX) is better than MTX in the 
treatment of murine collagen-induced arthritis. Ann Rheum 
Dis 2008; 67: 1188–91.
Copyright © Experimental Oncology, 2009
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
0 10 0 10
Pre- Simultaneous
O
D4
92
Fig. 9. Effect of pre- or simultaneous treatment of K-562 cells with 
the FCS on the anti-tumor activity of MTX. K-562 cells (2 x 105/flask) 
were incubated with (10%) or without FCS in 3 ml of Cosme-
dium-001 at 37 °C for 48 h. After washing the cells twice with 3 ml 
of PBS, they were incubated (5 x 103/well) with ( ) or without ( ) 
0.1 μM MTX in 200 μl Cosmedium-001 at 37 °C for 48 h (Pre-). Alter-
natively, K-562 cells were incubated with ( ) or without ( ) 0.1 μM 
MTX in the presence (10%) or absence of FCS at 37 °C for 48 h 
(simultaneous). Vertical bars represent SD of 4 determinants
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Fig. 10. Interaction between MTX and the suppressive molecules in 
the FCS. MTX (0.2 μM) was incubated with ( ) or without ( ) 20% 
FCS in 500 μl Cosmedium-001 at 37 °C for 24 h. The media were 
ultrafiltrated with a YM-100 filter, and the filtrate and the retentate 
were collected followed by reconstitution with Cosmedium-001. 
K-562 cells were incubated in 100 μl Cosmedium-001 with 100 μl of 
the filtrate or the retentate at 37 °C for 48 h. Vertical bars represent 
SD of 4 determinants
